One of the most exciting discoveries of the last two decades has been the identification of a large number of non-coding RNAs and the realization that they play essential roles in mammalian development and in diseases. Their study and the characterization of their contribution to the pathogenesis of human cancer is the central focus of our group. To learn more about our lab, please visit our blog and webpage at: www.venturalaboratory.com.
Andrea Ventura, MD, PhD
Research FocusCancer biologist Andrea Ventura studies non-coding RNAs in cancer and development
- MD, Catholic University of Rome (Italy)
- PhD, European Institute of Oncology (Milan Italy), Open University (London, UK)
- Postdoctoral, Center for Cancer Research, Massachusetts Institute of Technology (Cambridge, MA)
- Perez AR, Pritykin Y, Vidigal JA, Chhangawala S, Zamparo L, Leslie CS, Ventura A. GuideScan software for improved single and paired CRISPR guide RNA design. Nat Biotechnol. 2017 Mar 6. doi: 10.1038/nbt.3804. [Epub ahead of print] PMID: 28263296
- Han YC, Vidigal JA, Mu P, Yao E, Singh I, González AJ, Concepcion CP, Bonetti C, Ogrodowski P, Carver B, Selleri L, Betel D, Leslie C, Ventura A. An allelic series of miR-17～92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat Genet. 2015 Jun 1. doi: 10.1038/ng.3321. [Epub ahead of print] PubMed PMID: 26029871.